Stay updated on Pembrolizumab + Radiation in SCCHN Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Radiation in SCCHN Clinical Trial page.

Latest updates to the Pembrolizumab + Radiation in SCCHN Clinical Trial page
- Check4 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a newer version of the page.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedNew guidance sections were added to help users understand the study record and how to join, including 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. A recruitment status update shows that no longer looking for participants, and formatting changes removed 'Intervention / Treatment' while the revision note was updated to v3.6.0.SummaryDifference0.4%

- Check25 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4, indicating a software revision tag rather than substantive changes to trial details.SummaryDifference0.1%

- Check46 days agoChange DetectedA new revision tag, v3.5.4, has been added, replacing v3.5.3. This indicates a small platform update applied to the page rather than a change to study data or visible content.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page’s UI/version label was updated from Revision v3.5.2 to v3.5.3, reflecting a platform/document version change rather than a change to the clinical trial information.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab + Radiation in SCCHN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Radiation in SCCHN Clinical Trial page.